Sudarshana Purkayastha

Affiliations: 
Albert Einstein College of Medicine, USA 
Area:
NFkB pathway :cardiovascular & metabolic disorders
Google:
"Sudarshana Purkayastha"
Mean distance: 22.67 (cluster 59)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tang Y, Purkayastha S, Cai D. (2015) Hypothalamic microinflammation: a common basis of metabolic syndrome and aging. Trends in Neurosciences. 38: 36-44
Yan J, Zhang H, Yin Y, et al. (2014) Obesity- and aging-induced excess of central transforming growth factor-β potentiates diabetic development via an RNA stress response. Nature Medicine. 20: 1001-8
Li J, Tang Y, Purkayastha S, et al. (2014) Control of obesity and glucose intolerance via building neural stem cells in the hypothalamus. Molecular Metabolism. 3: 313-24
Purkayastha S, Cai D. (2013) Neuroinflammatory basis of metabolic syndrome. Molecular Metabolism. 2: 356-63
Cai D, Purkayastha S. (2013) A New Horizon: Oxytocin as a Novel Therapeutic Option for Obesity and Diabetes. Drug Discovery Today. Disease Mechanisms. 10: e63-e68
Purkayastha S, Cai D. (2013) Disruption of neurogenesis by hypothalamic inflammation in obesity or aging. Reviews in Endocrine & Metabolic Disorders. 14: 351-6
Zhang G, Li J, Purkayastha S, et al. (2013) Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH. Nature. 497: 211-6
Purkayastha S, Ford J, Kanjilal B, et al. (2012) Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions. Journal of Neurochemistry. 120: 396-407
Levano K, Punia V, Raghunath M, et al. (2012) Atp8a1 deficiency is associated with phosphatidylserine externalization in hippocampus and delayed hippocampus-dependent learning. Journal of Neurochemistry. 120: 302-13
Purkayastha S, Zhang G, Cai D. (2011) Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB. Nature Medicine. 17: 883-7
See more...